KORU Medical Systems, Inc. Common Stock (DE) financials
$3.01−1.80%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.0M | $11.8M | $10.9M | $10.4M | $10.2M | $9.6M | $8.8M | $8.2M | $8.4M | $8.2M | $7.2M | $7.0M |
| Gross profit | $7.8M | $7.2M | $6.8M | $6.3M | $6.5M | $6.0M | $5.6M | $5.2M | $5.5M | $5.1M | $4.3M | $4.3M |
| Gross margin | 65.1% | 61.5% | 62.6% | 60.2% | 63.5% | 62.8% | 62.9% | 63.4% | 65.0% | 62.3% | 60.3% | 62.0% |
| Operating income | $627.0K | -$864.9K | -$547.1K | -$867.7K | -$312.7K | -$1.2M | -$1.6M | -$1.7M | -$1.2M | -$2.0M | -$2.2M | -$1.8M |
| Net income | $252.4K | -$807.1K | -$486.9K | -$778.0K | -$206.9K | -$1.2M | -$1.6M | -$1.6M | -$988.7K | -$1.9M | -$7.5M | -$1.4M |
| Net margin | 2.1% | −6.9% | −4.5% | −7.5% | −2.0% | −12.1% | −17.7% | −19.3% | −11.7% | −23.6% | −103.9% | −19.5% |
| Diluted EPS | $0.01 | $-0.02 | $-0.01 | $-0.02 | $0.00 | $-0.03 | $-0.03 | $-0.03 | $-0.02 | $-0.04 | $-0.16 | $-0.03 |
| EBITDA | $837.0K | -$667.4K | -$367.9K | -$663.2K | -$103.2K | -$1.0M | -$1.4M | -$1.5M | -$974.2K | -$1.7M | -$2.0M | -$1.6M |
| Operating cash flow | $216.1K | $14.7K | $1.1M | $65.5K | -$460.3K | -$237.5K | $939.6K | -$923.9K | $11.3K | -$346.7K | $1.1M | -$1.2M |
| Free cash flow | $108.2K | -$31.5K | $687.0K | $13.0K | -$489.2K | -$680.9K | $896.0K | -$2.0M | -$112.9K | -$479.8K | $900.8K | -$1.4M |
| Diluted shares | 49.5M | 46.4M | 46.3M | 46.2M | 46.2M | 46.0M | 45.8M | 45.9M | 45.8M | 45.7M | 45.7M | 45.6M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.3M | $8.8M | $8.9M | $8.5M | $8.1M | $8.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $220.0K | $172.9K | $203.6K | $571.4K | $264.1K | $428.5K |
| Total assets | $28.0M | $28.6M | $28.2M | $27.1M | $25.5M | $27.2M |
| Total liabilities | $9.9M | $11.7M | $11.2M | $10.6M | $9.0M | $10.9M |
| Shareholders' equity | $18.1M | $16.9M | $17.0M | $16.5M | $16.5M | $16.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology